Pediatrics And Children's Health Archives

This year’s match results show that only 91.8% of pediatric residency slots were successfully filled by programs compared to a higher percentage in years past. This ongoing outcome has many physicians in the field worried about the declining interest in pediatric subspecialties. Katherine Jordan, MD, and Priyanka Rao, MD, at the UNC School of Medicine wrote a JAMA perspective piece asking, “Where are all the pediatricians?”

Vanderbilt University Medical Center is launching a first-in-human clinical trial to determine the safety and efficacy of an experimental monoclonal antibody against enterovirus D68 (EV-D68). UNC School of Medicine’s Matthew Vogt, MD, PhD, was a postdoctoral fellow in Pediatric Infectious Diseases at VUMC when he co-led the development of monoclonal antibody therapies against EV-D68.

After a thorough systematic analysis, Micheal Sandbank, PhD, at the UNC School of Medicine and other researchers across the United States found that evidence was lacking that higher intensity interventions provided increased benefits for young autistic children.

This five-year grant from the National Institute of Allergy and Infectious Diseases is led by Toni Darville, MD, director of the UNC Children’s Research Institute, in collaboration with scientists at Vaxcyte, Inc. and the University of Chicago.

Brooke Matson, Jeremy Meier, Brittany Raffa, and Shivani Sud will receive support from the UNC School of Medicine Physician Scientists Training Program to cultivate their careers as translational clinical scientists.

‘Clinic on wheels’ will offer important tests and services for children, especially in rural areas.

UNC Children's hosted the UNC-Dunkin' Prom for teen patients on Friday, April 12. The night was filled with teens walking the red carpet and dancing the night away!

The University of North Carolina at Chapel Hill was one of four academic medical centers on the study, which shows that an intervention program developed by the American Academy of Pediatrics can dramatically reduce injuries in young children.

The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.

A woman with blonde hair and a white lab coat stands with hands in her pockets

A research study named Early Check has screened 1,000 newborns after birth in an effort to help identify rare conditions early, provide treatment, give parents educational information, and connect families with specialists throughout the state of North Carolina.

Stage one results from the OUtMATCH clinical trial, published in the New England Journal of Medicine, show that a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as age one could consume without an allergic reaction. Edwin Kim, MD, Corinne Keet, MD, PhD, and Mike Kulis, PhD, are contributing authors.

Sydney and Sheridan Taylor of Durham, North Carolina, have lived with this rare genetic disorder all of their lives. They and their mother, Helena, recount how far they have come since her daughters became patients at UNC Hospitals more than two decades ago and what more needs to be done during pain crises and emergency visits.

Category: Pediatrics And Children’s Health

Disinterest in Pediatric Care? Jordan and Rao Pen Perspective Piece on Pediatric Workforce Decline

Antibody Trial Launched to Address Enterovirus Threat

New Study Suggests Higher Amounts of Intervention May Not Be More Helpful for Children on the Autism Spectrum

UNC School of Medicine Leads $9.3-Million Study to Create Chlamydia Vaccine

Four Scholars Named to Physician Scientist Training Program

UNC Health Rolls Out New Hearing and Speech Mobile Clinic

UNC Children’s Dunkin’ Prom

Researchers Show Injury Prevention Program Reduces Injuries in Young Children

How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis

A Newborn Genetic Screening Study Reaches New Milestone

Drug in OUtMATCH Clinical Trial FDA-Approved for the Reduction of Allergic Reactions from Accidental Food Exposures

How Two Sisters Continue to Soar with Sickle Cell Disease